Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
9.38
+0.07 (0.75%)
At close: Sep 26, 2025, 4:00 PM EDT
9.65
+0.27 (2.88%)
After-hours: Sep 26, 2025, 7:55 PM EDT
Tempest Therapeutics Market Cap
Tempest Therapeutics has a market cap or net worth of $41.65 million as of September 26, 2025. Its market cap has increased by 19.73% in one year.
Market Cap
41.65M
Enterprise Value
36.03M
1-Year Change
19.73%
Ranking
Category
Stock Price
$9.38
Market Cap Chart
Since June 28, 2021, Tempest Therapeutics's market cap has decreased from $88.65M to $41.65M, a decrease of -53.02%. That is a compound annual growth rate of -16.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 41.65M | 14.36% |
| Dec 31, 2024 | 36.42M | -57.00% |
| Dec 29, 2023 | 84.69M | 600.22% |
| Dec 30, 2022 | 12.09M | -66.85% |
| Dec 31, 2021 | 36.49M | -58.84% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 651.40B |
| Johnson & Johnson | 430.03B |
| AbbVie | 388.80B |
| UnitedHealth Group | 311.55B |
| Novo Nordisk | 251.02B |
| Novartis AG | 237.03B |
| Abbott Laboratories | 232.72B |
| AstraZeneca | 226.78B |